Market Overview

Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19

Share:

In a report from Jefferies' Corey Davis published Tuesday, the analyst suggested Elan (NYSE: ELN) execs have indicated they may agree or strongly consider a takeover anywhere between $15 to $20 per share.

Davis's analysis supports a $19/share bid, but only from a "high taxpaying suitor."

Davis named some potential strategic buyers: Allergan (NYSE: AGN), Regeneron (NASDAQ: REGN), Vertex (NASDAQ: VRTX), Alexion (NASDAQ: ALXN), Zoetis (NYSE: ZTS), Mylan (NASDAQ: MYL), and Perrigo (NYSE: PRGO)n

Jefferies maintains a Buy rating; the price target was raised from $14 to $19.

The stock is up 2 percent to $13.76 in early-morning trade.

Latest Ratings for ELN

DateFirmActionFromTo
Jul 2013JefferiesDowngradesBuyHold
Jun 2013JefferiesMaintainsBuy
Feb 2013Leerink SwannUpgradesUnderperformMarket Perform

View More Analyst Ratings for ELN
View the Latest Analyst Ratings

 

Related Articles (ELN)

View Comments and Join the Discussion!

Posted-In: Analyst Color M&A News Price Target Analyst Ratings

Latest Ratings

StockFirmActionPT
OCXBTIGInitiates Coverage On5.0
GCMGWilliam BlairInitiates Coverage On
PDCraig-HallumInitiates Coverage On41.0
CAPLWells FargoDowngrades
MMPWells FargoDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com